Skip to main content
Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc. — Investor Relations & Filings

Ticker · EWTX ISIN · US28036F1057 US Manufacturing
Filings indexed 367 across all filing types
Latest filing 2025-11-14 Director's Dealing
Country US United States of America
Listing US EWTX

About Edgewise Therapeutics, Inc.

https://edgewisetx.com/

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for severe and rare muscle disorders. The company leverages its expertise in muscle science to create precision medicines for conditions including muscular dystrophies and serious cardiac diseases. Its primary goal is to develop treatments that address the underlying causes of these debilitating conditions to improve the lives of patients and their families.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-11-14 English
PRIMARY DOCUMENT
Director's Dealing
2025-11-14 English
PRIMARY DOCUMENT
Director's Dealing
2025-11-14 English
Regulatory Filings 2025
Regulatory Filings
2025-11-12 English
FORM 8-K
Regulatory Filings
2025-11-10 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.